(AP) -- Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers Squibb and AstraZeneca.
Jul 15, 2011
1
0
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound ...
Jun 14, 2022
0
8
Patients with active asthma—such as any use of asthma medications, and unscheduled office or emergency visits for asthma—are at a twofold risk of having a heart attack, according to Mayo Clinic research presented at the ...
Nov 16, 2014
1
0
Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain. ...
May 15, 2011
0
0
The black-legged tick -loaded with bacteria causing Lyme disease - may have some good qualities: its spit.
Sep 7, 2017
0
2
New data published today suggest that several commonly used machine learning algorithms (MLAs) can effectively predict which hospitalized patients will become infected with Clostridiodes difficile (C. diff). The findings, ...
Jan 20, 2022
0
5
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...
May 16, 2012
0
0
The lifetime risk of lower-extremity peripheral artery disease (PAD), in which leg arteries narrow abnormally, is about 30 percent for black men and 28 percent for black women, with lower but still-substantial risks for Hispanics ...
Sep 10, 2019
0
23
Although the prevalence and impact of cancer-related fatigue has been well established, very little is known about its predictors, mechanisms for development, and persistence post-treatment. A new research study at the Cedars-Sinai ...
Dec 18, 2013
0
0
Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to a study led by researchers from The Royal Marsden ...
Apr 25, 2022
0
44
